HGF and Parkinson disease: HGF gene therapy employing naked plasmids succeeds in preventing neuronal death in animal models of ALS (Sun et al., 2002) and PD (Koike et al., 2006, 2009) and induces analgesic effects in a neuropathic pain model (Nho et al., 2018).